Medicine & Health

A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

A new study from researchers at Washington University School of Medicine and colleagues at other institutions details a new tool that can quickly identify the presence of Ebola virus in blood samples. The technology has potential to be developed into a rapid diagnostic test.

Polina V. Lishko, a noted molecular biologist and entrepreneur, has been named a BJC Investigator at Washington University School of Medicine.

Antibiotics inappropriately prescribed to children resulted in at least $74 million in excess health-care costs in the U.S. in 2017, according to a new study from Washington University School of Medicine and The Pew Charitable Trusts.

Vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System.

Researchers at Washington University School of Medicine and the University of Wisconsin–Madison identified the genetic causes of three mitochondrial diseases by figuring out what dozens of poorly understood mitochondrial proteins do.

People with neurofibromatosis type 1 develop tumors on nerves throughout their bodies. Washington University School of Medicine researchers have discovered a way to use the epilepsy drug lamotrigine to stop such tumor growth in mice.

Washington University School of Medicine has received a $61 million grant renewal for its Institute of Clinical and Translational Sciences to support clinical and translational research across the region.

Researchers at Washington University School of Medicine and Saint Louis University found that less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication.

Medical student Morgan Pfeiffer donated her kidney to a baby while an undergraduate student. She will earn her medical degree from Washington University this month and, next, start her residency at St. Louis Children’s Hospital.